The European Union's health care system is in dire need of reform, according to a new report from the EU Health Coalition.
The report, which the Pharmaceutical Executive calls "a vision for European health," calls for "a Europe where health and care systems are withoutshoringes," investing in "human, intellectual, and innovation capital, and alertness to innovative health technologies and clinical practices," and creating a "single market" for drugs.
It also calls for the sharing of health data, but says this should be done in a way that doesn't "waste the opportunity for innovation because it lacks clarity and disdains trade secrets."
The report comes as the pharmaceutical industry in Europe is trying to shift its focus to more "sympathetic regions of the world," the Guardian reports.
"Simply put, innovative drugmakers in Europe feel under threat from excessive regulation, hostility to intellectual property rights, and indifference to their economic equilibrium and global competitiveness," the report says.
The industry is also worried about competition from cheaper, generic drugs.
The report comes as the EU is debating a bill that would require all new drugs on the market for more than a year to be approved by the EU's Medicines Agency, the BBC reports.
The bill is expected to be voted on in Read the Entire Article
A customized collection of grant news from foundations and the federal government from around the Web.
Giraffe, the South African start-up using technology to help tackle unemployment in South Africa through an automated recruitment service, has announced it has raised a seed round of funding led by Silicon Valley venture firm Omidyar Network.